CAR-T was developed to wipe out hard-to-treat blood cancers. But the cells that go bad in leukemias and lymphomas — immune ...

Scientists at Children's Medical Research Institute (CMRI) have made a major discovery about cancer cells. This new ...

AstraZeneca advances its ambition to redefine hematology care with new data from its diverse pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

Cancer cells with a cell nucleus that is easily deformed are more sensitive to drugs that damage DNA. These are the findings of a new study by researchers at Linköping University in Sweden.

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

Scientists are learning how to revive faltering human cells by loading them with fresh power plants, effectively repairing ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:00 AM ESTCompany ParticipantsPeter Griffith - Executive VP & ...